17:29 EST Immix Biopharma (IMMX) files $750M mixed securities shelf
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMMX:
- Immix Biopharma price target raised to $12 from $8 at H.C. Wainwright
- Immix Biopharma Enters Underwriting Agreement with Morgan Stanley
- Immix Biopharma Announces Positive Phase 2 Trial Results
- Immix Biopharma 19.12M share Spot Secondary priced at $5.10
- Immix Biopharma announces phase 2 NXC-201 results